Medical Communications
Angle PLC announces identifying therapeutic targets in TNBC patients
March 25, 2022 Medical Communications
A leading cancer research institute in Milan, Italy, Fondazione IRCCS Istituto Nazionale dei Tumori, has published results of a study …
FDA grant Breakthrough Therapy Designation for RSV vaccine candidate in older adults
March 25, 2022 Medical Communications
Pfizer has announced that its respiratory syncytial virus (RSV) vaccine candidate has received Breakthrough Therapy Designation from the FDA, for …
ViiV Healthcare announces label update for long-acting HIV treatment
March 25, 2022 Medical Communications
The FDA has approved a label update for Cabenuva (cabotegravir, rilpivirine), which makes the oral lead-in with cabotegravir and rilpivirine …
Ipsen appoints Guy Oliver as General Manager, UK & Ireland
March 21, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Ipsen have announced the appointment of Guy Oliver as General Manager of its UK and Ireland affiliate. Guy brings a …
Moderna seeks FDA authorisation for fourth COVID-19 jab for adults
March 18, 2022 Medical Communications
Moderna has requested an EUA from the FDA for a fourth dose of its COVID-19 vaccine, as a booster for …
NIH fund research for Short Bowel Syndrome
March 18, 2022 Medical Communications
A Saint Louis University School of Medicine physician-scientist has received funding of $428,020, from the National Institutes of Allergy and …
GSK halts new clinical trials in Russia
March 18, 2022 Medical Communications
Britain’s second biggest drugmaker, GlaxoSmithKline (GSK), has joined other pharmaceutical companies including Pfizer, sharing that it will not start clinical …
AstraZeneca could abandon US regulatory efforts for COVID-19 vaccine
March 18, 2022 Medical Communications
The Oxford/AstraZeneca vaccine has not yet been approved in the US, and has not been submitted for Emergency Use Authorisation …
Valneva provides regulatory update on COVID-19 vaccine candidate
March 11, 2022 Medical Communications
Valneva has announced an update on the regulatory review of its inactivated COVID-19 vaccine candidate VLA2001, by the CHMP.The company …
Asia’s COVID-19 deaths surpass one million
March 11, 2022 Medical Communications
A Reuters tally has revealed that Asia passed the milestone of one million coronavirus-linked deaths on Friday 11 March. A …
WHO advises Ukraine to destroy disease-causing pathogens in labs
March 11, 2022 Medical Communications
WHO has advised Ukraine to destroy “disease-causing pathogens” kept in public health labs, to prevent “any potential spills”, Reuters has …
NIHR unites with health and social care leaders to improve public research involvement
March 11, 2022 Medical Communications
The National Institute for Health Research (NIHR) has announced a new shared commitment to improve public health in research. The …
Phase III trial into nirsevimab for RSV treatment yields positive results
March 4, 2022 Medical Communications
The latest results from Sanofi and AstraZeneca’s Phase III trial nirsevimab support the vaccine’s ability to protect all infants from …
Median Technologies iBiopsy Lung Cancer Screening Software
March 4, 2022 Medical Communications
Median Technologies has announced that the company has filed a regulatory submission to the FDA for its iBiopsy Lung Cancer …
Promising treatment targeting 40% mortality Candida infection
March 4, 2022 Medical Communications
A Promising Innovation Medicine (PIM) designation has been awarded to rezafungin by the MHRA, for the treatment of invasive candidiasis. …
Latest content
October 28, 2026
Acumetis CEO Herspiegel steps down as Burden assumes role
October 27, 2026
